Tetanus Toxoid (Tt) Vaccine Suppliers & Bulk Manufacturers
Available Forms: Lyophilized powder, Suspension
Available Strengths: 0.5 mL
Reference Brands: Adacel(US)
Category:
Vaccines
Tetanus Toxoid (TT) vaccine stimulates the immune system to produce protective antibodies against tetanus toxin. It prevents tetanus infection, reduces disease severity, and supports long-term immunity. Benefits include lifelong protection, decreased tetanus cases, and safeguarding individuals from a potentially fatal disease through routine immunization.
Tetanus Toxoid (TT) Vaccine is available in Lyophilized powder, Suspension
and strengths such as 0.5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Tetanus Toxoid (TT) Vaccine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Tetanus Toxoid (TT) Vaccine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Tetanus Toxoid (TT) vaccine is approved in the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in accordance with GMP standards. In the US, FDA approval involves rigorous clinical evaluation, while in the EU, CE marking certifies conformity with in vitro diagnostic and medicinal regulations. These vaccines undergo validation, stability testing, and quality audits, with comprehensive documentation including safety profiles, clinical trial data, and manufacturing practices. For licensing procedures, approved dossiers, and latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective tetanus prophylaxis globally, essential for routine immunization and outbreak prevention.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing